Skip to main content
. Author manuscript; available in PMC: 2023 May 21.
Published in final edited form as: Endocr Pract. 2022 Aug 11;28(10):923–1049. doi: 10.1016/j.eprac.2022.08.002

Table 1.

Summary of Questions

Q = Question
Section 1 Screening, diagnosis, glycemic targets, glycemic monitoring
Q1 How is the diagnosis of DM made and what is the current screening protocol for prediabetes and diabetes?
Q2 What are the glycemic treatment goals for persons with DM?
Q3 When and how should glucose monitoring be used?
Section 2 Comorbidities and complications
Q4 How should hypertension be managed in persons with DM?
Q5 How should dyslipidemia be managed in persons with DM?
Q6 How should DKD or CKD in DM be managed?
Q7 How should retinopathy be managed in persons with DM?
Q8 How should neuropathy be diagnosed and managed in persons with DM?
Q9 How should antihyperglycemic agents be prioritized in persons with T2D at high risk for/or with established CVD?
Q10 How should obesity be managed in persons with DM?
Section 3 Management
Q11 How should prediabetes be managed?
Q12 How can glycemic targets be achieved in persons with T2D?
Q13 How should insulin therapy be used for management of persons with T1D?
Q14 How should hypoglycemia be managed?
Q15 How should DM be managed in the hospital?
Q16 How should DM in pregnancy be managed?
Section 4 Education and other topics
Q17 What education interventions have been shown to be most effective in management of persons with DM?
Q18 What are the key nonpharmacological components of a comprehensive diabetes care plan in children and adolescents?
Q19.1 Should persons with infertility be screened for DM?
Q19.2 How should persons with preexisting diabetes mellitus and infertility be evaluated?
Q19.3 Should men with DM and cardiometabolic disorders be assessed for hypogonadism?
Q20.1 How should persons at risk for secondary diabetes be assessed?
Q20.2 What are the best treatment strategies for management of secondary diabetes, such as posttransplant diabetes, cystic fibrosis‒related diabetes, and other forms of secondary diabetes?
Q21 What is the role of sleep medicine in the care of persons with DM?
Q22 Should screening for depression be a routine component of clinical assessment in persons with DM?
Q23 Is the evaluation of SDOH in persons predisposed to or with DM useful in improving health outcomes?
Q24 Is telehealth/virtual care an effective care-delivery model for the management of persons with DM?
Q25 Which occupations have specific public safetyerelated diabetes management considerations?
Q26 Is there a role for nutritional supplements in the management of DM and what might be the associated risks?
Q27 How should potential increased cancer risk be managed in persons with obesity/T2D?
Q28 Which vaccinations should be given to adults with DM?

Abbreviations: CKD, chronic kidney disease; CVD, cardiovascular disease; DKD, diabetic kidney disease; DM, diabetes mellitus; SDOH, social determinants of health; T1D, type 1 diabetes, T2D, type 2 diabetes.